Interest in predictive testing for Parkinson's disease: Impact of neuroprotective therapy
Nabila Dahodwala, Andrew Siderowf, Danna Jennings, M. B. Stern(Duke University), Jennifer Farmer(Hospital of the University of Pennsylvania), James L. Connolly(Beth Israel Deaconess Medical Center)
Cited by 20
Related Papers
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2.8k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k
Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|988